semaglutide in kidney disease and Survival Outcomes with by... : Clinical Journal of the American Society of Nephrology Acute Kidney Injury Associated With

Implications of the trial results for Ozempic and GLP-1 drugs The results of the trial could expand Ozempics (and eventually other GLP-1 receptor agonists) indications to treat many more conditions for people with type 2 diabetes

One of the most common causes of kidney disease is diabetes, particularly type 2 diabetes, which has also been growing dramatically in recent decades, he said

The FDA has reported adverse-event concerns involving compounded semaglutide and tirzepatide, including dosing errors, gastrointestinal symptoms, and events that required medical attention

Both alcohol and semaglutide affect the GI system

If nausea starts, stop drinking and hydrate